Retransplantation after post-transplant lymphoproliferative diseases (PTLD): when is it safe?
Hanto
Douglas W
DW
D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D008232:Lymphoproliferative Disorders / Q000503:physiopathology*; D011183:Postoperative Complications / Q000503:physiopathology*; D012086:Reoperation; D012449:Safety